Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
A recently approved plaque-tracking dye can improve doctors’ ability to identify Alzheimer’s.
A maverick neuroscientist believes he has deciphered the code by which the brain forms long-term memories.
In a small trial, patients given an existing drug showed no cognitive decline over three years.
When he learned in 1995 that he had Alzheimer’s disease, William Utermohlen, an American artist living in London, immediately began work on an ambitious series of self-portraits.
Companies hope that brain stimulation will work where drugs have failed.